Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.

ABSTRACT:

Introduction

COVID-19 particularly impacted patients with co-morbid conditions, including cancer. Patients with melanoma have not been specifically studied in large numbers. Here, we sought to identify factors that associated with COVID-19 severity among patients with melanoma, particularly assessing outcomes of patients on active targeted or immune therapy.

Methods

Using the COVID-19 and Cancer Consortium (CCC19) registry, we identified 307 patients with melanoma diagnosed with COVID-19. We used multivariable models to assess demographic, cancer-related, and treatment-related factors associated with COVID-19 severity on a 6-level ordinal severity scale. We assessed whether treatment was associated with increased cardiac or pulmonary dysfunction among hospitalized patients a

SUBMITTER: Johnson DB 

PROVIDER: S-EPMC10033295 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature